Table 3.
Patient characteristics and COVID-19 associated symptoms.
| LC+SAT+ED (n = 6) | LC+SAT (n = 18) | |
|---|---|---|
| Age (years) | 8–14 (Median 11.5) | 6–17 (Median 14) |
| Sex | 3 female, 3 male | 13 female, 5 male |
| Numbers of MD consultations since the first signs of long COVID before presentation at our Pediatric Infectious Diseases Outpatient Clinic | 1–5 (Median 2.5) | 1–5 (Median 3) |
| Fever: 4 (66.7%) | Fever: 4 (22.2%) | |
| Flu-like symptoms: 3 (50.0%) | Flu-like symptoms: 13 (72.2%) | |
| Chest pain: 2 (33.3%) | Chest pain: 1 (5.6%) | |
| Headache: 5 (83.3%) | Headache: 11 (61.1%) | |
| Initial symptoms during Covid 19 | Smell and taste dysfunction: 1 (16.7%) | Smell and taste dysfunction: 1 (5.6%) |
| Pain in Extremities: 1 (16.7%) | Pain in Extremities: 1 (5.6%) | |
| Vertigo: 2 (33.3%) | Vertigo: 9 (50.0%) | |
| Diarrhea: 0 (0.0%) | Diarrhea: 1 (5.6%) | |
| Unknown: 1 | Unknown: 10 | |
| Subtype of SARS-CoV2 (PCR) | Delta/Indian B.1.617.2: 4 | Delta/Indian B.1.617.2: 5 |
| Alpha/British B.1.1.7: 0 | Alpha/British B.1.1.7: 1 | |
| Omicron B.1.1.529: 2 | Omicron B.1.1.529: 2 | |
| SARS-CoV2-antibodies (BAU/ml) | 2020–0 (Median: 126) | >2090–0 (Median: 322) |
| Max. Loss of weight after COVID-19 (kilogram) | 4–6.5 (Median: 5) | 1 (No median, only 1 patient) |
| 95%-CI: 4.33–6.17 | 95%-CI: 0.0–0.17 | |
| Before long COVID: | Before long COVID: | |
| 18.1–23.1 | 15.5–25.7 | |
| 95%-CI: 17.7–22.1 | 95%-CI: 18.1–21.8 | |
| Actual BMI: | Actual BMI: | |
| Actual body mass index (and before long COVID) (kg/m2) | 14.8-18.4 | 15.5-25.7 |
| 95%-CI: 15.4–18.3 | 95%-CI: 18.2–22.1 | |
| BMI reduction: | BMI reduction: | |
| 95%-CI: 1.77-5.58 | 95%-CI: 0.0–0.18 | |
| Days until the symptoms improved | 0–84 | 0–120 days |